104 related articles for article (PubMed ID: 35026490)
1. Interval breast cancer is associated with interferon immune response.
Ugalde-Morales E; Grassmann F; Humphreys K; Li J; Eriksson M; Tobin NP; Lindström LS; Vallon-Christersson J; Borg Å; Hall P; Czene K
Eur J Cancer; 2022 Feb; 162():194-205. PubMed ID: 35026490
[TBL] [Abstract][Full Text] [Related]
2. Molecular Differences between Screen-Detected and Interval Breast Cancers Are Largely Explained by PAM50 Subtypes.
Li J; Ivansson E; Klevebring D; Tobin NP; Lindström LS; Holm J; Prochazka G; Cristando C; Palmgren J; Törnberg S; Humphreys K; Hartman J; Frisell J; Rantalainen M; Lindberg J; Hall P; Bergh J; Grönberg H; Czene K
Clin Cancer Res; 2017 May; 23(10):2584-2592. PubMed ID: 27587435
[No Abstract] [Full Text] [Related]
3. Risk factors and tumor characteristics of interval cancers by mammographic density.
Holm J; Humphreys K; Li J; Ploner A; Cheddad A; Eriksson M; Törnberg S; Hall P; Czene K
J Clin Oncol; 2015 Mar; 33(9):1030-7. PubMed ID: 25646195
[TBL] [Abstract][Full Text] [Related]
4. Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers.
Mandelson MT; Oestreicher N; Porter PL; White D; Finder CA; Taplin SH; White E
J Natl Cancer Inst; 2000 Jul; 92(13):1081-7. PubMed ID: 10880551
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer genetic risk profile is differentially associated with interval and screen-detected breast cancers.
Li J; Holm J; Bergh J; Eriksson M; Darabi H; Lindström LS; Törnberg S; Hall P; Czene K
Ann Oncol; 2015 Mar; 26(3):517-22. PubMed ID: 25488685
[TBL] [Abstract][Full Text] [Related]
6. Predicting interval and screen-detected breast cancers from mammographic density defined by different brightness thresholds.
Nguyen TL; Aung YK; Li S; Trinh NH; Evans CF; Baglietto L; Krishnan K; Dite GS; Stone J; English DR; Song YM; Sung J; Jenkins MA; Southey MC; Giles GG; Hopper JL
Breast Cancer Res; 2018 Dec; 20(1):152. PubMed ID: 30545395
[TBL] [Abstract][Full Text] [Related]
7. Screen-detected versus interval cancers: Effect of imaging modality and breast density in the Flemish Breast Cancer Screening Programme.
Timmermans L; Bleyen L; Bacher K; Van Herck K; Lemmens K; Van Ongeval C; Van Steen A; Martens P; De Brabander I; Goossens M; Thierens H
Eur Radiol; 2017 Sep; 27(9):3810-3819. PubMed ID: 28289944
[TBL] [Abstract][Full Text] [Related]
8. Novel mammographic image features differentiate between interval and screen-detected breast cancer: a case-case study.
Strand F; Humphreys K; Cheddad A; Törnberg S; Azavedo E; Shepherd J; Hall P; Czene K
Breast Cancer Res; 2016 Oct; 18(1):100. PubMed ID: 27716311
[TBL] [Abstract][Full Text] [Related]
9. "Association of mammographic features with molecular breast tumor profiles".
Sartor H; Zackrisson S; Hegardt C; Larsson C
Cancer Treat Res Commun; 2021; 28():100387. PubMed ID: 34004506
[TBL] [Abstract][Full Text] [Related]
10. Molecular comparison of interval and screen-detected breast cancers.
Cheasley D; Li N; Rowley SM; Elder K; Mann GB; Loi S; Savas P; Goode DL; Kader T; Zethoven M; Semple T; Fox SB; Pang JM; Byrne D; Devereux L; Nickson C; Procopio P; Lee G; Hughes S; Saunders H; Fujihara KM; Kuykhoven K; Connaughton J; James PA; Gorringe KL; Campbell IG
J Pathol; 2019 Jun; 248(2):243-252. PubMed ID: 30746706
[TBL] [Abstract][Full Text] [Related]
11. Derived mammographic masking measures based on simulated lesions predict the risk of interval cancer after controlling for known risk factors: a case-case analysis.
Hinton B; Ma L; Mahmoudzadeh AP; Malkov S; Fan B; Greenwood H; Joe B; Lee V; Strand F; Kerlikowske K; Shepherd J
Med Phys; 2019 Mar; 46(3):1309-1316. PubMed ID: 30697755
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Adjunctive Ultrasonography for Breast Cancer Detection Among Women Aged 40-49 Years With Varying Breast Density Undergoing Screening Mammography: A Secondary Analysis of a Randomized Clinical Trial.
Harada-Shoji N; Suzuki A; Ishida T; Zheng YF; Narikawa-Shiono Y; Sato-Tadano A; Ohta R; Ohuchi N
JAMA Netw Open; 2021 Aug; 4(8):e2121505. PubMed ID: 34406400
[TBL] [Abstract][Full Text] [Related]
13. A prospective comparative trial of adjunct screening with tomosynthesis or ultrasound in women with mammography-negative dense breasts (ASTOUND-2).
Tagliafico AS; Mariscotti G; Valdora F; Durando M; Nori J; La Forgia D; Rosenberg I; Caumo F; Gandolfo N; Sormani MP; Signori A; Calabrese M; Houssami N
Eur J Cancer; 2018 Nov; 104():39-46. PubMed ID: 30316869
[TBL] [Abstract][Full Text] [Related]
14. Mammographic density and survival in interval breast cancers.
Eriksson L; Czene K; Rosenberg LU; Törnberg S; Humphreys K; Hall P
Breast Cancer Res; 2013 Jun; 15(3):R48. PubMed ID: 23786804
[TBL] [Abstract][Full Text] [Related]
15. Survival and Disease-Free Survival by Breast Density and Phenotype in Interval Breast Cancers.
Sala M; Domingo L; Louro J; Torá-Rocamora I; Baré M; Ferrer J; Carmona-Garcia MC; Barata T; Román M; Macià F; Castells X;
Cancer Epidemiol Biomarkers Prev; 2018 Aug; 27(8):908-916. PubMed ID: 29853482
[No Abstract] [Full Text] [Related]
16. Automated Volumetric Analysis of Mammographic Density in a Screening Setting: Worse Outcomes for Women with Dense Breasts.
Moshina N; Sebuødegård S; Lee CI; Akslen LA; Tsuruda KM; Elmore JG; Hofvind S
Radiology; 2018 Aug; 288(2):343-352. PubMed ID: 29944088
[TBL] [Abstract][Full Text] [Related]
17. Evidence of the effect of adjunct ultrasound screening in women with mammography-negative dense breasts: interval breast cancers at 1 year follow-up.
Corsetti V; Houssami N; Ghirardi M; Ferrari A; Speziani M; Bellarosa S; Remida G; Gasparotti C; Galligioni E; Ciatto S
Eur J Cancer; 2011 May; 47(7):1021-6. PubMed ID: 21211962
[TBL] [Abstract][Full Text] [Related]
18. Effect of mammographic breast density on breast cancer screening performance: a study in Nijmegen, The Netherlands.
van Gils CH; Otten JD; Verbeek AL; Hendriks JH; Holland R
J Epidemiol Community Health; 1998 Apr; 52(4):267-71. PubMed ID: 9616416
[TBL] [Abstract][Full Text] [Related]
19. The effect of volumetric breast density on the risk of screen-detected and interval breast cancers: a cohort study.
Wanders JOP; Holland K; Karssemeijer N; Peeters PHM; Veldhuis WB; Mann RM; van Gils CH
Breast Cancer Res; 2017 Jun; 19(1):67. PubMed ID: 28583146
[TBL] [Abstract][Full Text] [Related]
20. Mammographic and clinical characteristics of different phenotypes of screen-detected and interval breast cancers in a nationwide screening program.
Baré M; Torà N; Salas D; Sentís M; Ferrer J; Ibáñez J; Zubizarreta R; Sarriugarte G; Barata T; Domingo L; Castells X; Sala M
Breast Cancer Res Treat; 2015 Nov; 154(2):403-15. PubMed ID: 26531756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
